Mark Hillman - Hillman Capital Management, Inc.
Holding/activity history for Gsk Plc (AP47)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | 0 | 0.00 | Sell 100.00% | 3.75 | SEC | ||
| 2022 Q2 | 236,834 | 3.75 | Add 0.49% | 0.02 | $43.53 | $10,309,000 | SEC |
| 2022 Q1 | 235,689 | 3.26 | Add 1.11% | 0.04 | $43.56 | $10,266,000 | SEC |
| 2021 Q4 | 233,099 | 3.53 | Reduce 3.59% | 0.12 | $44.10 | $10,280,000 | SEC |
| 2021 Q3 | 241,776 | 3.24 | Add 3.51% | 0.11 | $38.21 | $9,238,000 | SEC |
| 2021 Q2 | 233,575 | 3.54 | Add 0.65% | 0.02 | $39.82 | $9,301,000 | SEC |
| 2021 Q1 | 232,065 | 3.63 | Add 4,029.27% | 3.54 | $35.69 | $8,282,000 | SEC |
| 2020 Q4 | 5,620 | 0.11 | Buy | 0.11 | $36.83 | $207,000 | SEC |